Business · 10/01/2014Updated: 10/17/2026 · 1 min read
FDA Announces Enforcement Action Against Misbranded Codeine-Containing Prescription Drugs
The FDA plans to take enforcement action against unapproved and misbranded oral and injectable prescription drugs containing codeine, posing serious risks of addiction and competing with approved products, which may lack essential safety information.